Here's an answer to the question about the therapeutic uses of psilocybin, based on the provided sources and my knowledge:

Therapeutic Uses of Psilocybin

According to www.iAsk.Ai - Ask AI:

Psilocybin, a naturally occurring psychedelic compound found in "magic mushrooms," is showing promise as a therapeutic agent for various mental health conditions and substance use disorders. Research, particularly from institutions like Johns Hopkins Medicine and NYU Langone Health, has been at the forefront of exploring psilocybin's potential.

The Johns Hopkins Center for Psychedelic and Consciousness Research has been a leader in this field, with studies demonstrating the safety and efficacy of psilocybin in controlled settings with psychological support.[1] Their research, spanning over two decades, has produced over 150 peer-reviewed articles.[1]

Psilocybin has shown significant therapeutic effects in treating major depressive disorder. A study published in JAMA Psychiatry indicated that two doses of psilocybin, combined with supportive psychotherapy, led to rapid and substantial reductions in depressive symptoms, with many participants showing improvement and about half achieving remission within a four-week follow-up.[5] The magnitude of the effect was notably larger than that observed with traditional antidepressants.[5]

Psilocybin-assisted therapy has also shown promise in addressing anxiety and depression in individuals with life-threatening cancer diagnoses. Research from NYU Langone Health, published in the Journal of Psychopharmacology, demonstrated that a single dose of psilocybin, coupled with psychological counseling, significantly reduced mental distress in cancer patients for over six months.[9] Similar findings were reported by Johns Hopkins researchers.[9]

Psilocybin is also being investigated for its potential in treating substance use disorders, particularly alcohol use disorder. A study published in JAMA Psychiatry showed that psilocybin-assisted therapy helped individuals with alcohol use disorder reduce their drinking for at least eight months after their initial treatments.[7] More than 80% of those who received the psychedelic treatment reduced their drinking, and half of the participants quit drinking altogether.[7]

The therapeutic effects of psilocybin are often linked to the experience of a "mystical-type" experience during the session. Research suggests that these experiences can mediate positive therapeutic outcomes.[4]

It's important to note that psilocybin therapy is not a standalone treatment. It is most effective when administered in a controlled setting with trained professionals providing psychological support before, during, and after the sessions.[7] The set and setting are crucial for a positive outcome.[4]

The FDA has granted psilocybin "breakthrough therapy" designation for treatment-resistant depression, signaling its potential for major psychiatric advancements.[6] Successful phase 3 trials are underway, and psilocybin may receive FDA approval for psychiatric use between 2026 and 2028.[6]


Authoritative Sources

  1. ABOUT. [Johns Hopkins Center for Psychedelic and Consciousness Research]
  2. The Emerging Role of Psilocybin in Mental Health Treatment. [Mental Wellness Center]
  3. Psychedelic Treatment with Psilocybin Relieves Major Depression, Study Show. [Johns Hopkins Medicine]
  4. The Emerging Role of Psilocybin in Mental Health Treatment. [Mental Wellness Center]
  5. Psilocybin from mushroom may help people with alcohol use disorder. [NBC News]
  6. Single dose of hallucinogenic drug psilocybin relieves anxiety, depression in patients with advanced cancer. [NYU Langone Health]

Answer Provided by iAsk.ai – Ask AI.

Sign up for free to save this answer and access it later

Sign up →

Web Results

A Woman's Journey | Clinical Treatment with Psilocybin
https//www.youtube.com › watch
A Woman's Journey | Clinical Treatment with Psilocybin
Research has shown that clinical use of psilocybin can be a beneficial tool for mental health professionals in treating a variety of mental ...
Psychedelics Research and Psilocybin Therapy
https//www.hopkinsmedicine.org › psychiatry › research › psychedelics-research
Psychedelics Research and Psilocybin Therapy
Johns Hopkins Medicine was awarded a grant from the National Institutes of Health (NIH) to explore the potential impacts of psilocybin on tobacco addiction.
Center for Psychedelic Medicine in the Media
https//med.nyu.edu › departments-institutes › psychiatry › research › center-psychedelic-medicine › media
Center for Psychedelic Medicine in the Media
Time Magazine: Psilocybin Could Be a Therapeutic Breakthrough for Addiction... NYU Langone Health - Education & Research. © 2025 NYU Grossman School of Medicine ...
Psilocybin produces substantial and sustained decreases ...
https//pmc.ncbi.nlm.nih.gov › articles › PMC5367557
Psilocybin produces substantial and sustained decreases ...
High-dose psilocybin produced large decreases in clinician- and self-rated measures of depressed mood and anxiety, along with increases in quality of life.
Center for Psychedelic & Consciousness Research
https//hopkinspsychedelic.org
Center for Psychedelic & Consciousness Research
Our research is investigating therapeutic effects in people who suffer a range of challenging conditions including addiction (smoking, alcohol, other drugs of ...